Troponin T and I assays show decreased concentrations in heparin plasma compared with serum: Lower recoveries in early than in late phases of myocardial injury

Clinical Chemistry

Volumn 46, Issue 6, 2000, Pages 817-821

  Gerhardt, Willie ^a   Nordin, Gunnar ^a   Herbert, Ann Katrin ^a   Burzell, Birgitta Linåker ^a   Isaksson, Anders ^b   Gustavsson, Elisabeth ^c   Haglund, Sofie ^a   Müller Bardorff, Margit ^d   Katus, Hugo A ^d  

^a Department of Clinical Chemistry ^*  (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; TROPONIN T;

ANALYTIC METHOD; ANTIGEN BINDING; ARTICLE; BLOOD SAMPLING; CONFORMATIONAL TRANSITION; ENZYME IMMUNOASSAY; HEART MUSCLE INJURY; HEPARINIZATION; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; TITRIMETRY;

EID: 0034044081     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/46.6.817     Document Type: Article

References (14)

1. 1. Stockman W, Bablok W, Luppa P. Analytical performance of Elecsys 2010 - a multicentre evaluation [Abstract in English]. Wien Klin Wochenschr Suppl 1998;3:10-21.
2. 2. Hallermayer K, Klenner D, Vogel R. Use of recombinant human cardiac troponin T for standardization of third generation troponin T methods. Scand J Clin Lab Investig Suppl 1999;230:128-31.
3. 3. Wu AHB, Fen YJ, Moore R, Apple FS, McPherson PH, Buechler KF, Bodor G. Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I. Clin Chem 1998;44:1198-208.
4. 4. Katus HA, Remppis A, Neumann FJ, Scheffold T, Diederich KW, Kübler W. Intracellular compartmentation of cardiac troponin-T and its release kinetics in patients with perfused and non-reperfused myocardial infarction. Am J Cardiol 1991;67:1360-7.
5. 5. Remppis A, Scheffold T, Karrer O, Zehelein J, Hamm C, Grunig E, et al. Assessment of reperfusion of the infarct zone after myocardial infarction by serial cardiac troponin T measurements in serum Br Heart J 1994;71:242-8.
6. 6. Gerhardt W, Ljungdahl L. Detection of myocardial damage by serial measurements of cardiac troponin T, CK MBmass, and TROPT Rapid Test. Cardiovasc Drugs Ther 1997;11(Suppl 1):227-40.
7. 7. Hirsh J, Raschke R, Warkentin TE, Dalen JE, Deykin D, Foller L. Heparin: mechanism of action, pharmacokinetics, dosing, considerations, monitoring, efficacy, and safety. Chest 1995;108(Suppl 4):258S-75S.
8. 8. Dolci A. Biochemical markers of myocardial damage: what sample can we use? [Abstract]. Preanalytical Phase in Patient Care and Hospital Management, June 5-6, 1999, Pratolino-Florence, Italy.
9. 9. Katrukha AG, Bereznikova AV, Esakova TV, Petterson K, Lövgen T, Severina ME, et al. Troponin I is released in bloodstream of patients with myocardial infarction not in free form but as a complex. Clin Chem 1997;43:1379-85.
10. 10. Katrukha AG, Bereznikova AV, Filatov V, Esakova TV. Biochemical factors influencing measurement of cardiac troponin I. Clin Chem Lab Med 1999;37:1091-5.
11. 11. WHO. Use of anticoagulants in diagnostic laboratory investigations. WHO/DIL/LAB/99.1. http://whqlibdoc.who.int/hq/1999/ WHO_DIL_LAB_99.1.pdf (accessed February 24, 2000).
12. 12. Burnett RW, Covington AK, Fogh-Anderson N, Külpman WR, Maas AH, Müller-Plathe O. et al. Approved IFCC recommendation on whole blood sampling, transport and storage for simultaneous determination of pH, blood gases and electrolytes. Eur J Clin Chem Biochem 1995;33:247-53.
13. 13. Panteghini M, Apple FS, Christenson R, Dati F, Mair J, Wu AH. Proposal from IFCC Committee on Standardization of Markers of Cardiac Damage (C-SMCD). Recommendations on use of biochemical markers of cardiac damage in acute coronary syndromes. Scand J Clin Lab Investig 1999;59(Suppl 230):103-12.
14. 14. Wu HB, Apple FS, Gibler BW, Jesse RL, Warshaw MM, Valdes R. National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases. Clin Chem 1999;45:1104-21.